"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

Houston-based University of Texas MD Anderson Cancer Center and the University of Texas at Austin have launched a partnership in support of research projects designed to improve cancer prevention ...

“Our results show that by using NeuroSAFE, nearly twice as many men don’t have to face potentially life-changing loss of erectile function after prostate surgery,” says Professor Greg L. Shaw. “These ...

NOBODY WANTS TO find out they have prostate cancer. Yet the earlier it's detected, the better. The cancer is very treatable when it's discovered early; you’ll have the most treatment options ...

The University of Texas MD Anderson Cancer Center broke ground March 31 in Sugar Land on what will be the hospital system's largest Houston-area facility outside of the Texas Medical Center.

The members of the American Association for Cancer Research (AACR) have elected Keith T. Flaherty, MD, Fellow of the AACR Academy, as the AACR President-Elect for 2025-2026. Flaherty will become ...

Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of ...

In another statement on HHS restructuring, the American Society of Hematology expressed it was "gravely" concerned about ...

Vicero, Inc., a preclinical-stage biopharmaceutical company developing next-generation VINCOBODIES for immune-mediated ...